XML 49 R38.htm IDEA: XBRL DOCUMENT v3.25.3
Note 15 - Phaseone Divestiture (Tables)
9 Months Ended
Sep. 30, 2025
Wound Care [Member]  
Notes Tables  
Disposal Groups, Including Discontinued Operations [Table Text Block]
   

Balance at

December 31,

2024

 

ASSETS

       

Current assets:

       

Accounts receivable, net

  $ 6  

Inventory, net

    48  

Total current assets, discontinued operations

  $ 54  
         

LIABILITIES

       

Liabilities:

       

Current liabilities:

       

Accounts payable

  $ 43  

Total current liabilities, discontinued operations

  $ 43  
   

Three Months Ended

September

30,

   

Nine Months Ended

September 30,

 
   

2025

   

2024

   

2025

   

2024

 
                                 

Net sales

  $     $ 5     $ 122     $ 252  

Cost of goods sold

          62       75       144  

Gross profit

          (57 )     47       108  

Operating expenses:

                               

Research and development

          4       3       32  

Total operating expenses

          4       3       32  

Operating (loss) income

          (61 )     44       76  

Gain on divestiture

                500        

Net (loss) income from discontinued operations before income taxes

          (61 )     544       76  

(Benefit) Provision for income taxes

    (2 )           10        
                                 

Net income (loss) from discontinued operations, net of taxes

  $ 2     $ (61 )   $ 534     $ 76  
   

Nine Months Ended September 30,

 
   

2025

   

2024

 
                 

Operating activities:

               

Net income from discontinued operations

  $ 534     $ 76  

Adjustments to reconcile net loss to net cash used in operating activities:

               

Non-cash gain on divestiture

    (500 )      

Changes in operating assets and liabilities:

               

Accounts receivable

    6       6  

Inventory

    43       49  

Prepaid expenses and other current assets

           

Accounts payable and accrued liabilities

    (38 )     (65 )

Net cash provided by operating activities, discontinued operations

    45       66  
                 

Investing activities:

               

Proceeds from divestiture

    500        

Net cash provided by investing activities, discontinued operations

    500        
                 

Net increase in cash and cash equivalents, discontinued operations

  $ 545     $ 66